Chlorzoxazone
NDC 72336-225, Chlorzoxazone, tablet, from Lifsa Drugs LLC.
- Product NDC
- 72336-225
- Status
- Listed
- Labeler
- Lifsa Drugs LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214702
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72336-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLORZOXAZONE250 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72336-225-60 | 72336022560 | 60 TABLET in 1 BOTTLE (72336-225-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f222059-1ece-44f3-ae7f-d277e5bcaba4NADAC price for package 72336022560
GET /v1/drugs/nadac/72336022560
Use it
Look up 72336-225 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72336-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72336-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.